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Laparoscopic Radical Prostatectomy: Washington University
Initial Experience and Prospective Evaluation of 
Quality of Life
JAMIL REHMAN, M.D.,1 MAGED M. RAGAB, M.D.,2 RAMAKRISHNA VENKATESH, M.D.,2
JAIME LANDMAN, M.D.,2 DAVID LEE, M.D.,3 CATHY CHEN, M.D.,2 YAN YAN, M.D.,2
and CHANDRU P. SUNDARAM, M.D., FRCS4
ABSTRACT
Background and Purpose: The laparoscopic approach to radical prostatectomy offers an alternative to the
open surgical procedure with less morbidity. We prospectively collected data including a validated quality-
of-life questionnaires on our first 38 laparoscopic radical prostatectomies (LRPs). The first 10 patients (group
1), second 10 patients (group II), and the most recent 18 patients (group III) were examined separately to
study the learning curve for this procedure. In addition, we determined the pattern of recovery of urinary
continence, potency, and quality of life.
Patients and Methods: Between July 1999 and July 2002, 38 consecutive transperitoneal laparoscopic radi-
cal prostatectomies were performed for clinically localized prostate carcinoma. Patients completed quality-
of-life questionnaires (Rand 36 Health Survey) before surgery as well as at 1, 3, 6, and 12 months and every
6 months thereafter. The patients were also interviewed by an individual not directly involved in patient care.
Results: One patient (the second in our experience) was converted to the open approach because of failure
to progress. The average operating time for the whole series was 4236 137.6 minutes (range 215–825 min-
utes), the last 10 procedures taking 305 6 63 minutes (range 215–420 minutes). Complications consisted of
one case each of intraoperative bladder injury, transient superficial peroneal nerve palsy, pulmonary em-
bolism, and bladder neck obstruction. The bladder injury was closed laparoscopically without further com-
plication. Bladder neck obstruction was secondary to a bladder wall fold that was treated with transurethral
resection 14 months after surgery with good results. Four patients in group 1 had minor anastomotic leaks,
while only one patient after that had a leak (group III). Four patients required transfusion, two intraopera-
tively and two postoperatively. In group III, the urethral catheter remained in place for an average of 8 days
(range 6–10 days). With a mean follow-up of 22.8 months (range 9–43 months), 84.8% of the patients had
perfect urinary control. Postoperatively, 9 patients (27%) were fully continent on removal of the Foley cath-
eter. At 1, 3, 6, and 9 months postoperatively, diurnal urinary control was reported by 30.3%, 48%, 72.7%,
and 84.8% of the patients, respectively. One patient needed an artificial urinary sphincter. Among the in-
continent patients, 24.2% had urinary urgency, and one third of these patients reported urge incontinence.
Conclusions: Laparoscopic prostatectomy is a reproducible technique with a steep learning curve. Operat-
ing times and the incidence of anastomotic leaks and urinary incontinence decrease significantly after the ini-
tial 10 patients.
1Department of Urology, SUNY-Stony Brook University, School of Medicine, Stony Brook, New York.
2Department of Surgery, Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri.
3Department of Urology, University of California, School of Medicine Irvine, California.
4Department of Urology, Indiana University, School of Medicine, Indianapolis, Indiana.
INTRODUCTION
LAPAROSCOPIC RADICAL PROSTATECTOMY (LRP)remains a difficult intervention and continues to be called
into question as traditional retropubic prostatectomy sets higher
standards in terms of reduced operative time, small incision,
lower postoperative morbidity, and improved efficacy. The lap-
aroscopic approach facilitates better visibility of the surgical anat-
omy, precise dissection because of the magnification, less blood
loss secondary to the tamponading effect of the pneumoperi-
toneum, and a better urethrovesical anastomosis because the su-
tures are all applied and tied under direct vision. This in turn may
improve continence and potency by better preservation of the
urethral sphincter and neurovascular bundles. All these advan-
tages could provide shorter postoperative convalescence, de-
creased blood transfusion rates, possibly shorter hospitalization,
and early return to work and other normal activities.
As more centers begin to offer the laparoscopic approach,
the results, possible complications, and operative difficulties
during the early experience need to be determined. As surgical
cure rates for localized prostate cancer have improved consid-
erably, the functional sequelae of the treatment—urinary con-
tinence and potency—have moved to the forefront. Most of the
results described for LRP have been from European centers af-
ter extensive surgical experience. The aim of this study was to
analyze our preliminary results with LRP, including complica-
tions, technical difficulties, and short-term oncologic control,
functional outcome, and health-related quality of life (QOL).
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FIG. 1. Technique of LRP. (A) Superior peritoneal fold represents approximate location of ureters and base of bladder. Infe-
rior arch, nearly at depth of peritoneal reflection, is created by coming together of vasa in the midline, with seminal vesicles ly-
ing just laterally. (B) Retrovesical dissection of seminal vesicle and vas deferens directly at bottom of lower peritoneal reflec-
tion (ureter lies just lateral and posterior to vas deferens). Foley tip is useful landmark, as it lies anterior to two arches. (C)
Superior layer of Denonvilliers’ fascia has sagittal (cephalocaudal) striations caused by muscle fibers, whereas posterior layer is
fibrous. Denonvilliers’ fascia is cut horizontally immediately below the prostate, close to ampulla of vas and seminal vesicles.
Following cutting of inferior layer, yellow rectal fat becomes visible. (D) Anterior retropubic dissection to drop bladder. Impor-
tant landmarks are obliterated urachus (median umbilical ligament) in midline, Foley balloon and tip in bladder, the two oblit-
erated umbilical ligaments (medial umbilical ligaments), and vas deferens. Filling bladder facilitates dissection by identifying
contours. Bladder is dropped by incising parietal peritoneum lateral to bladder but medial to medial umbilical ligament.
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PATIENTS AND METHODS
Patients
From July 1999 to July 2002, 38 men underwent LRP for
localized prostate cancer. The mean preoperative serum prostate
specific antigen concentration was 4.56 2.08 ng/mL
(Hybritech assay), and the mean prostate volume on ultrasound
scan was 32.66 10.4 cc.
The patients completed the Rand 36 Health Survey 1.0 qual-
ity-of-life questionnaire (SF-36) before surgery as well as at 1,
3, 6, and 12 months and every 6 months thereafter. To com-
plete the postoperative information, patients were also inter-
viewed by an individual not directly involved in patient care.
Histopathology examination
The weight of the specimen, tumor volume, pathologic stage,
and surgical margin status were assessed. The radical prostatec-
tomy specimen was coated with India ink, and 2-mm shave mar-
gins were obtained from the bladder neck and distal urethral
margins. After fixation of the prostatectomy specimen in 10%
Formalin, the seminal vesicles were cut and put in separate cas-
settes. The prostate was sectioned at 3-mm intervals, bisected,
and submitted in an apical to basal examination, with each block
designated by quadrant (right apex, right base, left apex, and
left base.1 Gleason histologic grade was established,2 and the
primary and secondary Gleason grades and Gleason scores were
recorded.
Surgical technique
All patients were treated by a single surgeon (CPS). In the
first 10 patients (group 1) the surgery was assisted by a senior
laparoscopic surgeon (R.V. Clayman). In groups 2 (the second
group of 10) and 3 (the most recent 18), the assistant was a se-
nior resident or a laparoscopy fellow. The transperitoneal LRP
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FIG. 2. Technique of LRP (continued). (A) Incision of endopelvic fascia and division of puboprostatic ligaments. Superficial
veins coursing over prostate are coagulated using bipolar forceps and cut. Endopelvic fascia are incised with curved scissors on
both sides toward puboprostatic ligaments. (B) Ligation of deep dorsal venous complex with figure-of-eight Vicryl suture on 5/6
CT needle. (C) Bladder neck opening and its dissection. Retraction of prevesical fat superiorly will cause faint outline of prosta-
tovesical plane. Bladder neck is further identified with laparoscopic scissors that distinguish mobile bladder wall from solid
prostate gland. With further sharp and blunt dissection, circular detrusor fibers are seen, and bladder neck is preserved. Surgeon
identifies urethra and incises anterior wall to expose Foley catheter. (D) Posterior bladder neck dissection. With meticulous dis-
section, posterior bladder neck is incised, allowing access to previously dissected retrovesical space. Prostatic pedicles become
apparent at this point, as they have been completely dissected.
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FIG. 3. Technique of LRP (continued). (A) Division of
prostatic pedicles with or without preservation of neurovas-
cular bundles. If nerve sparing is desired, before bladder neck
dissection, the dissection is accomplished between the two
layers of lateral pelvic fascia: levator ani fascia (outer fas-
cial layer) and prostatic fascia proper (inner fascial layer cov-
ering prostate) The levator fascia is divided, being released
first at bladder neck and then toward apex of prostate. A sub-
tle groove then appears on posterolateral edge of prostate,
which helps direct dissection of bundle toward urethra. Neu-
rovascular bundles are identified by retracting prostate an-
teriorly. Prostate vascular pedicles are separated by thin fat
plane from posterolateral neurovascular bundles. Upward
traction on vas deferens and seminal vesicle exposes lateral
pedicles. As pedicles are cut and dissection progresses to
apex, metal sound in urethra helps retract prostate away from
either pedicle and define anatomy. (B) Prostate is removed
after cutting urethra and dividing rectourethralis muscle
while applying gentle traction. Preserved neurovascular bundle is shown. (C) Urethrovesical anastomosis with 6 to 12 in-
terrupted 2-0 Vicryl sutures on RB, or SH needle (5/8 or UR-6).
was performed in all patients using the Montsouris technique
(Figs. 1-3).3
Some minor modifications were used during the initial ex-
perience. The AESOP 3000 voice-activated robot helps ma-
neuver the laparoscope and provide a steady image. During the
anastomosis, the assistant could help with the laparoscope be-
cause frequent movement is required, which could be done in
less time by an assistant than by the robot. In group 1 patients,
a rectal bougie was used to avoid rectal injury. During retro-
vesical dissection, the vas deferens was traced to the prostate,
and the seminal vesicle was identified before transection of the
vas to avoid ureteral injury. If the vas deferens was not easily
identified in the pouch of Douglas, it could be found more eas-
ily along the lateral pelvic wall and traced posteriorly. In two
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TABLE 1. OPERATIVE DATA AND POSTOPERATIVE RECOVERY
Group 1 Group 2 Group 3
mean (range) mean (range) mean (range)
Conversion (N) 1 0 0
Operating time (min) 591 (465–825) 427 (420–540) 305 (250–420)a
Positive margins (%) 4 (40) 2 (20) 4 (22)
Urethral catheterization (days) 18.4 (14–30) 11.7 (10–14) 8 (6–10)
Hospital stay (days) 2.4 (2–4) 2.7 (2–7) 2.3 (1–6)
EBL (mL) 340 (200–500) 320 (100–500) 500 (100–1700)
Blood transfusion (N)
Intraoperative 2 0 0
Postopeative 0 1 1
aP , 0.001.
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patients, initial cystoscopic circumferential bladder-neck inci-
sion between the prostatic base and the bladder neck was per-
formed to help with bladder-neck dissection. However, this ma-
neuver was not particularly helpful, especially as the bladder
neck is clearly visible with a little experience. A 24F curved
urethral sound and perineal pressure with a sponge stick helps
reveal the urethral stump clearly during anastomosis. Bilateral
nerve sparing was done in all patients who were potent preop-
eratively.
Follow-up
A cystogram was performed 5 to 7 days after the surgery. If
no extravasation occurred at the anastomosis with Valsalva ma-
neuvers, the catheter was removed. If a leak was detected at the
anastomosis, the catheter was not removed, and the cystogram
was repeated after a week.
RESULTS
All but one of the procedures was completed laparoscopi-
cally. The operative time became significantly shorter with ex-
perience, decreasing from an average of 591 minutes to an av-
erage of 305 minutes (P , 0.001)(Table 1). With increasing
experience, there also was a decline in the likelihood of anas-
tomotic leak (Table 2) and positive surgical margins (Table 3)
and an improvement in the rate of urinary continence (no pads
required) (Table 4). The SF-36 questionnaire indicated stabil-
ity or improvement of most measures of quality of life at 6
months or later postoperatively (Fig. 4).
DISCUSSION
In 1991, Schuessler and colleagues4 performed the first lap-
aroscopic prostatectomy. They later reported their experience
with nine patients.5 They found that this technique did not of-
fer any advantages over open surgery. In 1997, Raboy and as-
sociates6 reported their first experience with extraperitoneal
LRP, with subsequent publication of the results in two patients.7
In 1999, Guillonneau and associates described the results of 65
patients undergoing transperitoneal LRP, of whom 91% were
treated exclusively with a laparoscopic approach.8 The mean
operating time was 265 minutes, which is similar to that of con-
ventional radical prostatectomy. In some centers, this procedure
is performed extraperitoneally,9,10 which currently is the pre-
ferred technique of one of authors (JR).
In our study, all procedures except one were completed lap-
aroscopically as planned. This is very similar to the outcome
of the initial series by Guillonneau and Vallancien.11 The av-
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TABLE 2. COMPLICATIONS AND MORBIDITY
Group 1 Group 2 Group 3
Bladder injury 1 0 0
Anastomotic leak 4 0 1
(extravasation)
Pulmonary embolus 0 1 0
Bladder neck 1 0 0
obstruction (stricture)
TABLE 3. PATHOLOGY DATA
Group 1 Group 2 Group 3
Stage (%) T1c (80) T1c (70) T1c (43)
T2a (20) T2a (30) T2a (21)
T2b (29)
T3a (7)
Mean Gleason score 6 6 6
Positive margins (%) 40 20 22
Apex (N) 0 0 2
Urethra (N) 2 2 2
Posterolateral (N) 2 0 0
Bladder neck (N) 0 0 0
Seminal vesicle (N) 0 0 0
TABLE 4. FUNCTIONAL AND ONCOLOGIC RESULTS
Group 1 Group 2 Group 3
Mean follow-up (mos) (range) 27.3 (9–34) 13.5 (8–18) 4.38 (1–8)
Continence (no pads) (%) 80 70 92.3a
Potency (%)
Preop 40 50 70
Postop 25 with Viagra 35 (without Viagra 45 (without
(without Viagra 0) 10%; with Viagra 25%) Viagra 20%; with
Viagra 25%)
Serum PSA (ng/dL)
Preop 4.2 (1–6.7) 3.9 (2–5.7) 5.25 (1–12)
Postop ,0.1b ,0.1 ,0.1c
aP , 0.0001.
bExcept one patient, who had rising PSA and was treated with radiotherapy. His PSA is 0.1 ng/mL.
cExcept one patient, whose patient PSA is stable at 0.4 ng/mL. This patient had perineural invasion.
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FIG. 4. Mean values on SF-36 QOL Health Survey Measurement (scale 0–100 for each measure) over time. (A) Physical func-
tioning. (B) Role physical. (C) Role emotional. (D) Vitality. (E) Emotional functioning. (F) Social functioning. (G) Pain index.
(H) General health perception. (I) Urinary functioning. (J) Bowel functioning. (K) Sexual functioning.
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FIG. 4. (continued)
erage operating time was 4236 137.6 minutes (range 215–825
minutes), with the last 10 procedures taking 3056 63 minutes
(range 215–420 minutes). The considerable learning curve of
this technique is reflected in the sequential reduction of the op-
erative times. The mean time in published series was 4 hours,11
4.7 hours,12 4.2 hours,13 and 5 hours.9 As experience becomes
more extensive, time decreases, and in those centers with ex-
perience beyond 100 cases, operative times of 3 to 4 hours have
become routine. For example, in the Cleveland Clinic experi-
ence, the mean operating time in the initial 50 cases was 5.2
hours, but it was reduced to 3.9 hours in the second 50 cases
(I.S. Gill, personal communication). The operating time is likely
to be shorter in the future as residents and fellows are exposed
to this procedure during their training. Mentorship also can re-
duce the operating time and complications associated with early
surgical experience.
We focused on cancer control, continence, and potency, in
that order. The effectiveness of radical prostatectomy is mea-
sured acutely by margin status (pathology) and in the longer
term by serum PSA concentration (biochemical) and cancer-
specific survival (biologic). Our cancer control results were at
least equivalent to those of conventional procedures. All but
two patients had postoperative PSA values ,0.1 ng/mL. One
patient in group I had rising PSA and received radiotherapy; he
now has a serum PSA concentration ,0.1 ng/mL. The second
patient (group III) has a PSA value stable at 0.4 ng/mL. In the
most recent update of the Guillonneau and Vallancien series,14
with all 1000 consecutive patients having a minimum follow-
up of 1 year, the pathologic stage was pT2aN0/Nx in 203 pa-
tients (20.3%), pT2bN0/Nx in 572 (57.2%), pT3aN0/Nx in 142
(14.2%), pT3bN0/Nx in 77 (7.7%), and pT1–3N1 in 6 (0.6%).
The positive surgical margin rate was 6.9%, 18.6%, 30%, and
34% for stages pT2a, pT2b, pT3a, and pT3b, respectively. The
main predictors of a positive surgical margin were preoperative
PSA, clinical stage, pathologic stage, and Gleason score. The
overall actuarial biochemical progression-free survival rate was
90.5% at 3 years. Our positive surgical margins rate was 20%
to 22% after the initial 10 cases. This rate decreased signifi-
cantly after we became more meticulous about the apical dis-
section. Moreover, the positive margin rate in some large open
retropubic prostatectomy series has been 20% to 39%.15,16 In
a recent publication comparing radical retropubic prostatec-
tomy, radical perineal prostatectomy, and LRP, there was no
difference in oncologic control in the three groups.17 Preserva-
tion of the neurovascular bundles in patients with localized tu-
mors had no significant effect on the subsequent risk of posi-
tive surgical margins or progression-free survival.
An important advantage of laparoscopic prostatectomy is the
reduced blood loss. Our mean blood loss was 393.5 mL (range
100–1700 mL), and only four patients required autologous
blood transfusion. The low blood loss is probably a result of
the compression of small and medium-sized veins by the in-
traperitoneal pressure (10–15 mm Hg) and the excellent iden-
tification of details under laparoscopic magnification. Bleeding
vessels are individually distinguishable and can be selectively
coagulated. The blood loss reported by other groups is 402 mL
(transfusion rate 10%),11 574 mL (transfusion rate 9%),9 and
185 mL (transfusion rate 2%).13 The transfusion rate was 31%
with an average of 2.1 units being given in the Heilbronn se-
ries,30 while the blood loss in series of Eden and colleagues av-
eraged 313 mL (range 50–1300 mL) with a transfusion rate of
3%.18 The average blood loss in open prostatectomy series is
800 to 1500 mL.15,16
Our mean hospital stay was 2.3 days (median 2 days). After
the first 20 patients, the urethral catheter remained in place for
an average of 8 days (range 6–10 days). This is similar to Eu-
ropean series, where times of 6.6 days,11 8 days,12 5.5 to 19
days,13 4.2 days,18 and 7 days9 have been reported. Four pa-
tients in group I had a small anastomotic leak, while only one
patient in group III had a leak.
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TABLE 5. INTRAOPERATIVE DATA ON LRP FROM MAJOR EUROPEAN AND US CENTERS
Mean OR Mean
time blood loss Transfusion Open
Series No. pts. (hours) (mL) (%) conversion (%)
Montsouris Institute, Paris 350 3.6 354 5.7 2.0
Guillonneau et al, 19998
Guillonneau et al, 200138
Creteil, Paris 134 3.5a NRb 2.9 0
Hoznek et al, 200139
Brussels 50 5.3 680 13 2.0
Bollens et al, 20019
Heilbronn, Germany 100 4.6 NR 31 5.0
Rassweiler et al, 200112
Berlin 145 4.3 185 1.3 0
Turk et al, 200129
Cleveland Clinic 50 5.4 225 2.0 2.0
Zippe et al, 200140
Eden series (UK) 100 4.08 313 3.0 1.0
Eden et al, 200218
Washington University 38 7.0 393 11 2.0
Current series, 2002
aExcluding first 20 patients, in which operative time was 6.5 hours.
bNot reported.
Urinary continence is a significant concern after open prosta-
tectomy and remains a cause of serious morbidity in a small
number of patients. In our study, 84.8% of the patients used no
pads. Postoperatively, 27% were fully continent on removal of
the Foley catheter; and at 1, 3, 6, and 9 months postoperatively,
diurnal urinary control was reported by 30.3%, 48%, 72.7%,
and 84.8% of patients, respectively. After the first 20 cases, our
urinary control rate was 92.3%, which coincides with the mod-
ified and meticulous apical dissection. One patient needed an
artificial urinary sphincter. Among the incontinent patients,
24.2% had urinary urgency, and one third of these patients re-
ported urge incontinence.
Litwin and colleagues, using standardized questionnaires,
found that only 61% of patients undergoing open prostatectomy
return to baseline urinary function by 1 year postoperatively.19
However, Walsh and associates20 found “urinary bother” to be
either “no problem” or only a “small problem” for 95% of pa-
tients at 1 year. In a similar study after open radical prostatec-
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TABLE 6. PATHOLOGIC AND POSTOPERATIVE DATA FROM MAJOR EUROPEAN AND US CENTERS
Positive Hospital
Path stage margins stay Catheter Continence (%)
Series (%) (%) (days) (days) (mos postop)
Montsouris Institute, Paris T2a (30.8) 15.0 6.0 6.6 72 (6)
Guillonneau and T2b (56.8)
Vallencien 20003,11 T3a (5.8)
T3b (5)
Heilbronn, Germany T1a/b (1) 16.0 NRa 8.0 81 (6)
Rassweiler 200129 T2a (20) (pT2 2.3,
T2b (29) pT3a 15,
T3a (26) pT3b 34)
T3b (20)
T4 (4)
Berlin T2 (61.6) 26.4 8.0 5.5 86 (6)
Turk 200113,29 T2c (38.4)
Brussels T1a (2.2) 22.0 NR 7.0 85 (6)
Bollens et al, 20019 T2b (8.5) (10.1 for initial
T2b (42.5) 10 patients;
T2c (2.2) decreased to
T3a (34) 5.5 in last 10
T3b (10.6) patients
Creteil, Paris T2a (88) 27.7 7.8 4.0 84 (1)
Abbou 2000,28,41 T3a (6.9) (16.8 in (6.1 after
T3b (5.1) pT2, 48.8 first 10
pT3) cases) .0
Cleveland Clinic 1st 50 29.5 2.1 15.0 91 (6)
Gill 2002 (personal
communication) 2nd 50 25.0 1.6 4.0 94 (6)
<300 LRP performed
Eden series (UK) T1a (2) 16.0 4.2 1st 32 patients 90 (12)
Eden et al18 T1a (1) (pT1, 15, 2–3 weeks;
T2b (57) pT2 16, next 12
T2b (28) pT3 33) patients 1–4
T2c (9) days;
T3a (1) remaining
T3b (2) patients 10
days
Washington University Group I 40.0 2.4 (2–4) 18.4 (14–30) 80 (9)
Current series, 2002 T1c (80)
T2a (20)
Group II 20.0 2.7 (2–7) 11.7 (10–14) 70 (9)
T1c (70)
T2a (30)
Group III 22.0 2.3 (1–6) 8 (6–10)b 92.3 (4)
T1c (43)
T2a (21)
T2b (29)
T3a (7)
aNR 5 not reported.
bOne patient, who had a catheter for 24 days for urinary incontinence, was excluded.
tomy, only 73.5% of patients listed urinary continence as “no
problem” or a “small problem” at 1 year.21 In the series re-
ported by Catalona and colleagues,22 recovery of continence
was strongly correlated with younger age. Using the validated
International Continence Society (ICS) male self-reported ques-
tionnaire, Guillonneau and Vallancien23 found that among their
first 133 patients with a minimum follow-up of 1 year, total
continence (no pads needed during the day or night) was re-
ported by 114 (85.5%), and another 14 (10.7%) were still wear-
ing one pad every 24 hours. Five patients (3.8%) were severely
incontinent. The continence rate in the literature has been be-
tween 78.3% and 93% at 1 year; however, the ICS question-
naire was not completed by the patients in all studies.12,13,18,25
A study using the ICS questionnaire24 found a much higher in-
cidence of incontinence than is reported in the literature.
Laparoscopy, which offers optimal visibility, allows excel-
lent identification and dissection of the neurovascular bundles
and offers the potential for higher postoperative potency rates.25
Guillonneau and associates23 report an erection rate of 59% at
6 months postoperatively, and Bollens and colleagues9 found a
9-month potency rate of 75% in patients who were potent pre-
operatively. Salomon and colleagues26 reported erections at 1
month in 40% of patients undergoing bilateral nerve-sparing
operation and in 22.2% of patients having a unilateral nerve-
sparing procedure. Subsequent follow-up showed a potency rate
of 53.8% compared with open surgery.27 In the series described
by Eden and associates,18 62% of patients were potent by 1 year
if bilateral nerve sparing was used. Since the initial 20 cases,
our potency rate in preoperatively potent patients is 45% with
Viagra (sildenafil). This is attributable to initial case selection.
The majority of our patients had moderate to severe erectile
dysfunction preoperatively.
Our initial complication rate is similar to that in other LRP
series. Complications consisted of one case each of intraoper-
ative bladder injury, transient superficial peroneal nerve palsy,
and bladder neck obstruction. The bladder injury was closed 
laparoscopically. The obstruction was caused by a bladder wall
fold that was treated with transurethral resection with good re-
sults 14 months after surgery. In the series reported by Abbou
and colleagues,28 the anastomotic stricture rate was 1.3%. At
the Annual Meeting of the EAU in 2002, Guillonneau and Val-
lancien reported overall complication rates of 5% (major) and
18% (minor). Turk29 and Rassweiler30 and their associates
noted overall complications rates of 12% and 19%, with the
majority of being minor.
Health-related QOL is important consideration when com-
paring different treatment modalities.31,32 The SF-3633 is a self-
administered questionnaire that measures general health-related
QOL utilizing eight scales: physical function, social function,
bodily pain, emotional well being, energy fatigue, general
health perceptions, role limitations caused by physical prob-
lems, and role limitations attributable to emotional problems.
These scales are scored separately from 0 to 100, with higher
scores signifying a better outcome. This questionnaire has been
validated in several populations.34 Surgery is still associated
with pain and morbidity during recovery from the incision.
Three months after open radical retropubic prostatectomy, 30%
to 40% of patients have returned to their preoperative physical,
mental, and social functioning, and this rate increases to 70%
at 6 months and 86% to 97% by 1 year.19,35 Quality-of-life is-
sues related to LRP have not been studied, but the reduced mor-
bidity from surgery and consequent faster full recovery resulted
in much better QOL measurements at each time point than are
seen in open-surgery series. Sexual functioning is low because
a high percentage of the patients selected for this initial series
had moderate to severe erectile difficulties preoperatively and
because during one’s initial experience, the nerve-sparing tech-
nique is difficult via a laparoscopic approach.
Robotic assistance could help shorten the learning curve as-
sociated with LRP.36,37 However, the cost of the robot and its
instrumentation may limit its application at this time.
CONCLUSION
The initial surgical experience with the LRP involves long
operating times and a steep and long learning curve. The oper-
ating times for laparoscopic prostatectomy decrease signifi-
cantly after the first 20 patients and will continue to decline
with increasing experience. The continence rate improves sig-
nificantly after the initial 20 patients, becoming similar to that
following open surgery. Minimal bleeding, reduced blood trans-
fusion rates, shorter hospitalization, and faster recovery are ad-
ditional advantages for laparoscopic procedures. In sum, in ex-
perienced hands, LRP provides results equal to those of open
surgery, as judged by local tumor control and the biochemical
recurrence rate, with reduced morbidity (Tables 5 and 6).
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